Concepedia

Author

H.-M. Reinold

Friedrich-Alexander-Universität Erlangen-Nürnberg

Also Known As

H. M. Reinold, H.-M. Reinold, H.M. Reinold, Heiko Reinold

35

Publications

1.6K

Citations

10

H-Index

40

Concepts

All Affiliations

Friedrich-Alexander-Universität Erlangen-NürnbergMax Planck Institute for Brain ResearchAin Shams UniversityMax Planck SocietyUniversity of Zurich
HR

About

H.-M. Reinold is an author at Friedrich-Alexander-Universität Erlangen-Nürnberg specializing in medicine, health sciences, and pain medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

1.2K

2

Health Sciences

4

4

1.1K

3

Cell Biology

1

1

601

4

Epidemiology

1

1

26

5

Hepatology

1

1

25

H.-M. Reinold

×

9

Publications

1.6K

Citations

9

H-Index

YearCitations

GlyR α3: An Essential Target for Spinal PGE <sub>2</sub> -Mediated Inflammatory Pain Sensitization

Ulrike B. Depner, Heinz Wässle, Seifollah Ahmadi,

Science

2004

601

Reversal of pathological pain through specific spinal GABAA receptor subtypes

Julia Knabl, Robert Witschi, Katharina M. Hösl,

Nature

2008

426

Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype

H.-M. Reinold, Seifollah Ahmadi, Ulrike B. Depner,

Journal of Clinical Investigation

2005

199

Variable sensitivity to noxious heat is mediated by differential expression of the CGRP gene

Jeffrey S. Mogil, Frank Miermeister, Frank Seifert,

Proceedings of the National Academy of Sciences

2005

160

Spinal prostaglandin E receptors of the EP2 subtype and the glycine receptor α3 subunit, which mediate central inflammatory hyperalgesia, do not contribute to pain after peripheral nerve injury or formalin injection

Katharina M. Hösl, H.-M. Reinold, Ulrike Müller,

Pain

2006

88

Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype

H.-M. Reinold, Seifollah Ahmadi, Ulrike B. Depner,

Journal of Clinical Investigation

2005

34

Prognostic value of clinical, laboratory, and histological characteristics in multiple myeloma: Improved definition of risk groups

D. Peest, R. Coldewey, H. Deicher,

European Journal of Cancer

1993

26

Serum concentration and urinary excretion of 3H-Ouabain in patients suffering from liver or kidney diseases

Hg. Lahrtz, H.-M. Reinold, Pieter A. van Zwieten

European Journal of Clinical Pharmacology

1969

25

Cyclic alternating chemotherapy of high-grade malignant non-Hodgkin lymphomas with VIM-Bleo and CHOP

B. Steinke, K. Bross, H.-M. Reinold,

European Journal of Cancer

1992

10

Page 1